Urethral bulking injection
Endoscopic or peri-urethral injection intended to improve outlet coaptation, usually with lower procedural burden but potential need for repeat treatment.
Interactive 3D Interactive urethral bulking injection Open the 3D animation Teaching catalogue only. This coverage record is not a patient pathway or operative instruction.
Typical place in practice
Selected stress urinary incontinence where the expected benefit and likelihood of repeat injection are acceptable.
Alternatives and neighbouring procedures
Conservative management, sling procedures, colposuspension, autologous fascial sling or artificial sphincter in selected specialist practice.
Same procedure family, explicit technique branches
These are variations of this canonical operation. Complication modules below identify whether they apply to all branches or only to named approaches.
Transurethral injection
Deposits agent under direct intraluminal vision.
Peri-urethral injection
Places agent from an external peri-urethral trajectory.
Repeat or top-up injection
Adds material when initial coaptation is insufficient or benefit wanes.
High-level sequence
Coverage outline only; not a step-by-step technical guide.
- Confirm stress leakage and counsel about expected durability
- Inspect the urethra and bladder neck
- Place controlled deposits at selected sites
- Assess coaptation without causing obstruction
- Confirm voiding and arrange outcome review
Every failure mode is its own module.
Timing and variation coverage are recorded for each module.
Urinary infection
Instrumentation and implanted material can be followed by infection.
Applies to: All variantsTransient or persistent retention
Swelling or excessive coaptation can impede bladder emptying.
Applies to: All variantsBleeding or urethral injury
Needle placement can cause mucosal trauma, haematuria or extravasation.
Applies to: All variantsMigration, granuloma or erosion
A bulking material can move, incite a local reaction or become exposed in the urinary tract.
Applies to: All variantsPersistent or recurrent incontinence
Incomplete response and loss of effect over time are important outcome limitations.
Applies to: All variantsSources for this module
UK governance and shared-decision requirements for female continence surgery.
Accessed 2026-08-03 · opens source European Association of Urology EAU Guidelines on Non-neurogenic Female LUTSFemale continence, bulking, sling, colposuspension and related procedures.
Accessed 2026-08-03 · opens source